VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EHA 2020 | Immunomodulation for improving long-term outcomes in myeloma

Michel Delforge, MD, PhD, University of Leuven, Leuven, Belgium, discusses immunomodulation as a foundation for improving long-term outcomes in newly diagnosed multiple myeloma. This interview was recorded via an online conference call with The Video Journal of Hematological Oncology (VJHemOnc).

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter